Delivery Order SPE2DB20D7066-SPE2DB25FC4VA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,997.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml contrast medium in 100ml infusion bottles. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside delivery order for medical imaging supplies. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml infusion bottles (100 ml units). The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,171.00 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Omnipaque 300 mg/mL contrast medium in 100 mL infusion bottles. This non-set-aside, firm fixed price delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a small-value transaction within the company's broader relationship with the Defense Logistics Agency's...
- The Defense Logistics Agency awarded a $4,057.92 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Omnipaque 350 mg/ml Pluspak 500ml, a diagnostic contrast agent used in medical imaging procedures. This firm fixed-price contract, with completion targeted for September 10, 2025, represents a competitively awarded, non-set-aside delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Omnipaque 240 mg/mL vials (10 mL) with a ceiling value of $1,719.30 under a firm fixed price contract type. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a $5,239.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Omnipaque 300 mg/ml in 100ml infusion bottles. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 15, 2025. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $1,582.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 180 mg/mL vials (10 mL units) on August 20, 2025, with a completion date of August 21, 2025. This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Omnipaque 350 mg/mL Pluspak 500mL, a contrast medium used in medical imaging procedures. Valued at $5,410.56 with a firm fixed price structure, this non-set-aside delivery order represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4VADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,077.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units). This firm fixed-price delivery order, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Omnipaque is a contrast medium commonly used in diagnostic imaging procedures, and this order fulfills a specific medical supply requirement within the federal healthcare procurement framework. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems globally. AmerisourceBergen's established role as a major pharmaceutical distributor and critical vendor within the Defense Health Agency and military healthcare supply chain demonstrates its capability to fulfill both routine and specialized medical procurement requirements through competitive federal contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/18/25 |